Current Research & Future Challenges


Vaccine development remains challenging because of the highly sophisticated evasion mechanisms of pathogens for which vaccines are not yet available. Recent years have witnessed both successes and failures of novel vaccine design and the strength of iterative approaches is increasingly appreciated. These combine discovery of novel antigens, adjuvants and vectors in the preclinical stage with computational analyses of clinical data to accelerate vaccine design. Reverse and structural vaccinology have revealed novel antigen candidates and molecular immunology has led to the formulation of promising adjuvants. Gene expression profiles and immune parameters in patients, vaccines and healthy controls have formed the basis for bio-signatures that will provide guidelines for future vaccine design


    Related Conference of Current Research & Future Challenges

    August 16-16, 2021

    3rd World Conference on Vaccine and Immunology

    Dubai, UAE
    August 27-28, 2021

    5th International Conference on Emerging Infectious Diseases

    Amsterdam, Netherlands
    September 20-21, 2021

    11th International Conference on Bacteriology and Infectious Diseases

    Cape Town, South Africa
    October 12-13, 2021

    International Conference on Vaccine and Vaccine research

    Manila, Philippines
    October 14-15, 2021

    13th Annual Conference on Clinical Immunology

    Cape Town, South Africa
    November 04-05, 2021

    9th World Summit on Immunology & Immunotherapy

    Prague, Czech Republic
    November 08-09, 2021

    International Conference on Immunology Research

    Las Vegas, USA
    February 07-08, 2022

    International Conference on Vaccine Research

    Paris, France
    March 21-22, 2022

    36th International Conference on Immunology

    Rome, Italy
    March 21-22, 2022

    15th Global Summit on Immunology and Cell Biology

    Tokyo, Japan

    Current Research & Future Challenges Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in